SUZHOU SINOVENT PHARMACEUTICALS CO LTD has a total of 27 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are SUZHOU SINOVENT PHARMA CO LTD, TAPESTRY PHARMACEUTICALS INC and ACCENDATECH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | United States | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Republic of Korea | 5 | |
#5 | Canada | 3 | |
#6 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Wu Yuchuan | 23 |
#2 | Hu Yonghan | 19 |
#3 | Chen Xi | 12 |
#4 | Huang Shaoqiang | 12 |
#5 | Zhu Jinlian | 12 |
#6 | Liu Xiao | 12 |
#7 | Li Xin | 8 |
#8 | Huang Bin | 8 |
#9 | Peng Wei | 8 |
#10 | Wu Dongdong | 8 |
Publication | Filing date | Title |
---|---|---|
WO2020114474A1 | Heterocyclic compound, application thereof and pharmaceutical composition containing same | |
AU2019312416A1 | Polysubstituted benzene compound and preparation method and use thereof | |
US2021046057A1 | Beta-lactamase inhibitor and use thereof | |
CA3088932A1 | Heterocyclic compound, preparation method and use thereof in medicine | |
US2019152952A1 | 5-aminopyrazole carboxamide derivative as BTK inhibitor and preparation method and pharmaceutical composition thereof | |
KR20180094880A | 5-membered heterocyclic amide-based WNT pathway inhibitor | |
EP3252048A1 | Sunitinib prodrug and pharmaceutical composition |